Skip to main content
Publication of the activity report and financial information for the first half-year (April – Sept. 2018)
December 3, 2018
Publication of the activity report and financial information for the first half-year on December 3, 2018
November 27, 2018
Partial exercise of the over-allotment option – Final amount of the share issue increased to €31.4m
November 5, 2018
Successful IPO of MedinCell
October 3, 2018
Teva to participate in MedinCell Initial Public Offering
September 26, 2018
MedinCell announces the extension of the subscription period for the shares offered as part of its initial public offering
September 25, 2018
MedinCell launches its initial public offering on the regulated market of Euronext in Paris
September 17, 2018
MedinCell announces filing of its document de base with the AMF, the first step towards its planned IPO on the regulated market of Euronext in Paris
September 5, 2018
EIB lends EUR 20m to innovative company MedinCell
March 22, 2018
MedinCell receives grant to develop long-acting injectable contraceptive
December 7, 2017
